Non-deletional alpha thalassaemia: a review

Area of Science:

• Genetics
• Molecular Biology
• Hematology

Background:

• Alpha thalassaemia is caused by mutations affecting alpha-globin gene synthesis.
• Severe phenotypes include haemoglobin Bart's (gene deletion) and haemoglobin H disease (one functional gene).
• Silent and carrier traits are generally asymptomatic.

Purpose of the Study:

• To elucidate the molecular mechanisms of alpha thalassaemia, particularly non-deletional forms.
• To highlight the need for better understanding of these disorders and potential therapeutic measures.
• To contribute to the knowledge of how defective alpha-globin production leads to alpha thalassaemia syndrome.

Main Methods:

• Literature review on molecular mechanisms of alpha thalassaemia.
• Analysis of clinical manifestations and genetic mutations.
• Discussion of therapeutic strategies and diagnostic advancements.

Main Results:

• Non-deletional alpha thalassaemia often presents with more severe phenotypes than deletional forms.
• Defective alpha-globin chain synthesis results from mutations in genes or regulatory elements.
• Molecular markers influence globin gene expression and developmental switching.

Conclusions:

• Increased awareness and screening programs (new-born, prenatal) are vital, especially in high-migration populations.
• Improved patient monitoring for alpha thalassaemia is necessary.
• Further research into molecular mechanisms and therapeutic interventions is required.